Clover Health Investments Income from Continuous Operations 2020-2025 | CLOV

Clover Health Investments income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Clover Health Investments Annual Income from Continuous Operations
(Millions of US $)
2024 $-46
2023 $-210
2022 $-255
2021 $-588
2020 $-136
2019 $-364
Clover Health Investments Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $-11
2025-03-31 $-1
2024-12-31 $-21
2024-09-30 $-9
2024-06-30 $7
2024-03-31 $-23
2023-12-31 $-68
2023-09-30 $-34
2023-06-30 $-29
2023-03-31 $-80
2022-12-31 $1
2022-09-30 $-75
2022-06-30 $-104
2022-03-31 $-75
2021-12-31 $-187
2021-09-30 $-35
2021-06-30 $-318
2021-03-31 $-48
2020-12-31 $-126
2020-09-30 $13
2020-06-30 $5
2020-03-31 $-28
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.368B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.824B 59.57
Tempus AI (TEM) United States $13.255B 0.00
Doximity (DOCS) United States $12.564B 55.90
Hims & Hers Health (HIMS) United States $10.250B 83.98
IRhythm Technologies (IRTC) United States $5.398B 0.00
Hinge Health (HNGE) United States $4.325B 0.00
Inspire Medical Systems (INSP) United States $2.713B 39.89
Privia Health (PRVA) United States $2.625B 194.46
Heartflow (HTFL) $2.547B 0.00
Phreesia (PHR) United States $1.833B 0.00
Enovis (ENOV) United States $1.782B 9.42
10x Genomics (TXG) United States $1.747B 0.00
Omnicell (OMCL) United States $1.503B 28.96
Schrodinger (SDGR) United States $1.446B 0.00
Azenta (AZTA) United States $1.401B 61.14
Claritev (CTEV) United States $1.196B 0.00
Evolent Health (EVH) United States $1.089B 0.00
Fulgent Genetics (FLGT) United States $0.657B 0.00
Zepp Health (ZEPP) Netherlands $0.585B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.493B 0.00
Talkspace (TALK) United States $0.447B 133.50
Butterfly Network (BFLY) United States $0.400B 0.00
Carlsmed (CARL) United States $0.365B 0.00
TruBridge (TBRG) United States $0.300B 52.66
Outset Medical (OM) United States $0.251B 0.00
Health Catalyst (HCAT) United States $0.246B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.228B 0.00
Nyxoah SA (NYXH) Belgium $0.218B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.171B 0.00
CareCloud (CCLD) United States $0.156B 7.08
ImmunoPrecise Antibodies (IPA) Canada $0.127B 0.00
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.084B 0.00
Pulmonx (LUNG) United States $0.072B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
PROFUSA (PFSA) United States $0.014B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00